There were 22 press releases posted in the last 24 hours and 166,034 in the last 365 days.

Global Pancreatic Cancer Drugs Industry

Pancreatic Cancer Drugs market worldwide is projected to grow by US$1. 4 Billion, driven by a compounded growth of 7. 7%. Endocrine, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pancreatic Cancer Drugs Industry" - https://www.reportlinker.com/p05818014/?utm_source=GNW
4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.4 Billion by the year 2025, Endocrine will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 6.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$49.7 Million to the region’s size and clout in the next 5 to 6 years. Over US$43.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Endocrine will reach a market size of US$64.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.3% over the next couple of years and add approximately US$396.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Amgen, Inc.; Celgene Corporation; Clovis Oncology; Eli Lilly and Company; F. Hoffmann-La Roche AG; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; PharmaCyte Biotech, Inc.; Teva Pharmaceutical Industries Ltd.


Read the full report: https://www.reportlinker.com/p05818014/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Pancreatic Cancer Drugs Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Pancreatic Cancer Drugs Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Pancreatic Cancer Drugs Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Pancreatic Cancer Drugs Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Endocrine (Type) World Market by Region/Country in US$
Million: 2018 to 2025
Table 5: Endocrine (Type) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 6: Endocrine (Type) Market Share Breakdown of Worldwide
Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Exocrine (Type) Potential Growth Markets Worldwide in
US$ Million: 2018 to 2025
Table 8: Exocrine (Type) Historic Market Perspective by
Region/Country in US$ Million: 2009 to 2017
Table 9: Exocrine (Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Biologic (Therapy) Geographic Market Spread Worldwide
in US$ Million: 2018 to 2025
Table 11: Biologic (Therapy) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2009 to 2017
Table 12: Biologic (Therapy) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Chemotherapy (Therapy) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Chemotherapy (Therapy) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Chemotherapy (Therapy) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Other Therapies (Therapy) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Other Therapies (Therapy) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 18: Other Therapies (Therapy) Market Share Distribution
in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Pancreatic Cancer Drugs Market Share (in %) by Company: 2019 &
2025
Table 19: United States Pancreatic Cancer Drugs Market
Estimates and Projections in US$ Million by Type: 2018 to 2025
Table 20: Pancreatic Cancer Drugs Market in the United States
by Type: A Historic Review in US$ Million for 2009-2017
Table 21: United States Pancreatic Cancer Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 22: United States Pancreatic Cancer Drugs Market
Estimates and Projections in US$ Million by Therapy: 2018 to
2025
Table 23: Pancreatic Cancer Drugs Market in the United States
by Therapy: A Historic Review in US$ Million for 2009-2017
Table 24: United States Pancreatic Cancer Drugs Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
CANADA
Table 25: Canadian Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 26: Canadian Pancreatic Cancer Drugs Historic Market
Review by Type in US$ Million: 2009-2017
Table 27: Pancreatic Cancer Drugs Market in Canada: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 28: Canadian Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 29: Canadian Pancreatic Cancer Drugs Historic Market
Review by Therapy in US$ Million: 2009-2017
Table 30: Pancreatic Cancer Drugs Market in Canada: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
JAPAN
Table 31: Japanese Market for Pancreatic Cancer Drugs: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2018-2025
Table 32: Pancreatic Cancer Drugs Market in Japan: Historic
Sales Analysis in US$ Million by Type for the Period 2009-2017
Table 33: Japanese Pancreatic Cancer Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 34: Japanese Market for Pancreatic Cancer Drugs: Annual
Sales Estimates and Projections in US$ Million by Therapy for
the Period 2018-2025
Table 35: Pancreatic Cancer Drugs Market in Japan: Historic
Sales Analysis in US$ Million by Therapy for the Period
2009-2017
Table 36: Japanese Pancreatic Cancer Drugs Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
CHINA
Table 37: Chinese Pancreatic Cancer Drugs Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 38: Pancreatic Cancer Drugs Historic Market Analysis in
China in US$ Million by Type: 2009-2017
Table 39: Chinese Pancreatic Cancer Drugs Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 40: Chinese Pancreatic Cancer Drugs Market Growth
Prospects in US$ Million by Therapy for the Period 2018-2025
Table 41: Pancreatic Cancer Drugs Historic Market Analysis in
China in US$ Million by Therapy: 2009-2017
Table 42: Chinese Pancreatic Cancer Drugs Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Pancreatic Cancer Drugs Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 43: European Pancreatic Cancer Drugs Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 44: Pancreatic Cancer Drugs Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 45: European Pancreatic Cancer Drugs Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 46: European Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 47: Pancreatic Cancer Drugs Market in Europe in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 48: European Pancreatic Cancer Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 49: European Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Therapy: 2018-2025
Table 50: Pancreatic Cancer Drugs Market in Europe in US$
Million by Therapy: A Historic Review for the Period 2009-2017
Table 51: European Pancreatic Cancer Drugs Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
FRANCE
Table 52: Pancreatic Cancer Drugs Market in France by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 53: French Pancreatic Cancer Drugs Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 54: French Pancreatic Cancer Drugs Market Share Analysis
by Type: 2009 VS 2019 VS 2025
Table 55: Pancreatic Cancer Drugs Market in France by Therapy:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 56: French Pancreatic Cancer Drugs Historic Market
Scenario in US$ Million by Therapy: 2009-2017
Table 57: French Pancreatic Cancer Drugs Market Share Analysis
by Therapy: 2009 VS 2019 VS 2025
GERMANY
Table 58: Pancreatic Cancer Drugs Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 59: German Pancreatic Cancer Drugs Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 60: German Pancreatic Cancer Drugs Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 61: Pancreatic Cancer Drugs Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Therapy for
the Period 2018-2025
Table 62: German Pancreatic Cancer Drugs Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 63: German Pancreatic Cancer Drugs Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
ITALY
Table 64: Italian Pancreatic Cancer Drugs Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 65: Pancreatic Cancer Drugs Historic Market Analysis in
Italy in US$ Million by Type: 2009-2017
Table 66: Italian Pancreatic Cancer Drugs Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 67: Italian Pancreatic Cancer Drugs Market Growth
Prospects in US$ Million by Therapy for the Period 2018-2025
Table 68: Pancreatic Cancer Drugs Historic Market Analysis in
Italy in US$ Million by Therapy: 2009-2017
Table 69: Italian Pancreatic Cancer Drugs Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 70: United Kingdom Market for Pancreatic Cancer Drugs:
Annual Sales Estimates and Projections in US$ Million by Type
for the Period 2018-2025
Table 71: Pancreatic Cancer Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Type for the Period
2009-2017
Table 72: United Kingdom Pancreatic Cancer Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 73: United Kingdom Market for Pancreatic Cancer Drugs:
Annual Sales Estimates and Projections in US$ Million by
Therapy for the Period 2018-2025
Table 74: Pancreatic Cancer Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Therapy for the
Period 2009-2017
Table 75: United Kingdom Pancreatic Cancer Drugs Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
SPAIN
Table 76: Spanish Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 77: Spanish Pancreatic Cancer Drugs Historic Market
Review by Type in US$ Million: 2009-2017
Table 78: Pancreatic Cancer Drugs Market in Spain: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 79: Spanish Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 80: Spanish Pancreatic Cancer Drugs Historic Market
Review by Therapy in US$ Million: 2009-2017
Table 81: Pancreatic Cancer Drugs Market in Spain: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
RUSSIA
Table 82: Russian Pancreatic Cancer Drugs Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 83: Pancreatic Cancer Drugs Market in Russia by Type: A
Historic Review in US$ Million for 2009-2017
Table 84: Russian Pancreatic Cancer Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 85: Russian Pancreatic Cancer Drugs Market Estimates and
Projections in US$ Million by Therapy: 2018 to 2025
Table 86: Pancreatic Cancer Drugs Market in Russia by Therapy:
A Historic Review in US$ Million for 2009-2017
Table 87: Russian Pancreatic Cancer Drugs Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 88: Rest of Europe Pancreatic Cancer Drugs Market
Estimates and Forecasts in US$ Million by Type: 2018-2025
Table 89: Pancreatic Cancer Drugs Market in Rest of Europe in
US$ Million by Type: A Historic Review for the Period 2009-2017
Table 90: Rest of Europe Pancreatic Cancer Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 91: Rest of Europe Pancreatic Cancer Drugs Market
Estimates and Forecasts in US$ Million by Therapy: 2018-2025
Table 92: Pancreatic Cancer Drugs Market in Rest of Europe in
US$ Million by Therapy: A Historic Review for the Period
2009-2017
Table 93: Rest of Europe Pancreatic Cancer Drugs Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 94: Asia-Pacific Pancreatic Cancer Drugs Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 95: Pancreatic Cancer Drugs Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 96: Asia-Pacific Pancreatic Cancer Drugs Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 97: Pancreatic Cancer Drugs Market in Asia-Pacific by
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 98: Asia-Pacific Pancreatic Cancer Drugs Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 99: Asia-Pacific Pancreatic Cancer Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 100: Pancreatic Cancer Drugs Market in Asia-Pacific by
Therapy: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 101: Asia-Pacific Pancreatic Cancer Drugs Historic Market
Scenario in US$ Million by Therapy: 2009-2017
Table 102: Asia-Pacific Pancreatic Cancer Drugs Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
AUSTRALIA
Table 103: Pancreatic Cancer Drugs Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 104: Australian Pancreatic Cancer Drugs Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 105: Australian Pancreatic Cancer Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 106: Pancreatic Cancer Drugs Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Therapy for
the Period 2018-2025
Table 107: Australian Pancreatic Cancer Drugs Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 108: Australian Pancreatic Cancer Drugs Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
INDIA
Table 109: Indian Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 110: Indian Pancreatic Cancer Drugs Historic Market
Review by Type in US$ Million: 2009-2017
Table 111: Pancreatic Cancer Drugs Market in India: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 112: Indian Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 113: Indian Pancreatic Cancer Drugs Historic Market
Review by Therapy in US$ Million: 2009-2017
Table 114: Pancreatic Cancer Drugs Market in India: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
SOUTH KOREA
Table 115: Pancreatic Cancer Drugs Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Type
for the Period 2018-2025
Table 116: South Korean Pancreatic Cancer Drugs Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 117: Pancreatic Cancer Drugs Market Share Distribution in
South Korea by Type: 2009 VS 2019 VS 2025
Table 118: Pancreatic Cancer Drugs Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Therapy for the Period 2018-2025
Table 119: South Korean Pancreatic Cancer Drugs Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 120: Pancreatic Cancer Drugs Market Share Distribution in
South Korea by Therapy: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 121: Rest of Asia-Pacific Market for Pancreatic Cancer
Drugs: Annual Sales Estimates and Projections in US$ Million by
Type for the Period 2018-2025
Table 122: Pancreatic Cancer Drugs Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Type
for the Period 2009-2017
Table 123: Rest of Asia-Pacific Pancreatic Cancer Drugs Market
Share Analysis by Type: 2009 VS 2019 VS 2025
Table 124: Rest of Asia-Pacific Market for Pancreatic Cancer
Drugs: Annual Sales Estimates and Projections in US$ Million by
Therapy for the Period 2018-2025
Table 125: Pancreatic Cancer Drugs Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Therapy
for the Period 2009-2017
Table 126: Rest of Asia-Pacific Pancreatic Cancer Drugs Market
Share Analysis by Therapy: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 127: Latin American Pancreatic Cancer Drugs Market Trends
by Region/Country in US$ Million: 2018-2025
Table 128: Pancreatic Cancer Drugs Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 129: Latin American Pancreatic Cancer Drugs Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 130: Latin American Pancreatic Cancer Drugs Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 131: Pancreatic Cancer Drugs Historic Market Analysis in
Latin America in US$ Million by Type: 2009-2017
Table 132: Latin American Pancreatic Cancer Drugs Market by
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 133: Latin American Pancreatic Cancer Drugs Market Growth
Prospects in US$ Million by Therapy for the Period 2018-2025
Table 134: Pancreatic Cancer Drugs Historic Market Analysis in
Latin America in US$ Million by Therapy: 2009-2017
Table 135: Latin American Pancreatic Cancer Drugs Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 136: Argentinean Pancreatic Cancer Drugs Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 137: Pancreatic Cancer Drugs Market in Argentina in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 138: Argentinean Pancreatic Cancer Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 139: Argentinean Pancreatic Cancer Drugs Market Estimates
and Forecasts in US$ Million by Therapy: 2018-2025
Table 140: Pancreatic Cancer Drugs Market in Argentina in US$
Million by Therapy: A Historic Review for the Period 2009-2017
Table 141: Argentinean Pancreatic Cancer Drugs Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
BRAZIL
Table 142: Pancreatic Cancer Drugs Market in Brazil by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 143: Brazilian Pancreatic Cancer Drugs Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 144: Brazilian Pancreatic Cancer Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 145: Pancreatic Cancer Drugs Market in Brazil by Therapy:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 146: Brazilian Pancreatic Cancer Drugs Historic Market
Scenario in US$ Million by Therapy: 2009-2017
Table 147: Brazilian Pancreatic Cancer Drugs Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
MEXICO
Table 148: Pancreatic Cancer Drugs Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 149: Mexican Pancreatic Cancer Drugs Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 150: Mexican Pancreatic Cancer Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 151: Pancreatic Cancer Drugs Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Therapy for
the Period 2018-2025
Table 152: Mexican Pancreatic Cancer Drugs Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 153: Mexican Pancreatic Cancer Drugs Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 154: Rest of Latin America Pancreatic Cancer Drugs Market
Estimates and Projections in US$ Million by Type: 2018 to 2025
Table 155: Pancreatic Cancer Drugs Market in Rest of Latin
America by Type: A Historic Review in US$ Million for 2009-2017
Table 156: Rest of Latin America Pancreatic Cancer Drugs Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 157: Rest of Latin America Pancreatic Cancer Drugs Market
Estimates and Projections in US$ Million by Therapy: 2018 to
2025
Table 158: Pancreatic Cancer Drugs Market in Rest of Latin
America by Therapy: A Historic Review in US$ Million for
2009-2017
Table 159: Rest of Latin America Pancreatic Cancer Drugs Market
Share Breakdown by Therapy: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 160: The Middle East Pancreatic Cancer Drugs Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 161: Pancreatic Cancer Drugs Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 162: The Middle East Pancreatic Cancer Drugs Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 163: The Middle East Pancreatic Cancer Drugs Market
Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Table 164: The Middle East Pancreatic Cancer Drugs Historic
Market by Type in US$ Million: 2009-2017
Table 165: Pancreatic Cancer Drugs Market in the Middle East:
Percentage Share Breakdown of Sales by Type for 2009, 2019,
and 2025
Table 166: The Middle East Pancreatic Cancer Drugs Market
Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
Table 167: The Middle East Pancreatic Cancer Drugs Historic
Market by Therapy in US$ Million: 2009-2017
Table 168: Pancreatic Cancer Drugs Market in the Middle East:
Percentage Share Breakdown of Sales by Therapy for 2009, 2019,
and 2025
IRAN
Table 169: Iranian Market for Pancreatic Cancer Drugs: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2018-2025
Table 170: Pancreatic Cancer Drugs Market in Iran: Historic
Sales Analysis in US$ Million by Type for the Period 2009-2017
Table 171: Iranian Pancreatic Cancer Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 172: Iranian Market for Pancreatic Cancer Drugs: Annual
Sales Estimates and Projections in US$ Million by Therapy for
the Period 2018-2025
Table 173: Pancreatic Cancer Drugs Market in Iran: Historic
Sales Analysis in US$ Million by Therapy for the Period
2009-2017
Table 174: Iranian Pancreatic Cancer Drugs Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
ISRAEL
Table 175: Israeli Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 176: Pancreatic Cancer Drugs Market in Israel in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 177: Israeli Pancreatic Cancer Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 178: Israeli Pancreatic Cancer Drugs Market Estimates and
Forecasts in US$ Million by Therapy: 2018-2025
Table 179: Pancreatic Cancer Drugs Market in Israel in US$
Million by Therapy: A Historic Review for the Period 2009-2017
Table 180: Israeli Pancreatic Cancer Drugs Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 181: Saudi Arabian Pancreatic Cancer Drugs Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 182: Pancreatic Cancer Drugs Historic Market Analysis in
Saudi Arabia in US$ Million by Type: 2009-2017
Table 183: Saudi Arabian Pancreatic Cancer Drugs Market by
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 184: Saudi Arabian Pancreatic Cancer Drugs Market Growth
Prospects in US$ Million by Therapy for the Period 2018-2025
Table 185: Pancreatic Cancer Drugs Historic Market Analysis in
Saudi Arabia in US$ Million by Therapy: 2009-2017
Table 186: Saudi Arabian Pancreatic Cancer Drugs Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 187: Pancreatic Cancer Drugs Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2018-2025
Table 188: United Arab Emirates Pancreatic Cancer Drugs
Historic Market Analysis in US$ Million by Type: 2009-2017
Table 189: Pancreatic Cancer Drugs Market Share Distribution in
United Arab Emirates by Type: 2009 VS 2019 VS 2025
Table 190: Pancreatic Cancer Drugs Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Therapy for the Period 2018-2025
Table 191: United Arab Emirates Pancreatic Cancer Drugs
Historic Market Analysis in US$ Million by Therapy: 2009-2017
Table 192: Pancreatic Cancer Drugs Market Share Distribution in
United Arab Emirates by Therapy: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 193: Pancreatic Cancer Drugs Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Type for the Period 2018-2025
Table 194: Rest of Middle East Pancreatic Cancer Drugs Historic
Market Analysis in US$ Million by Type: 2009-2017
Table 195: Rest of Middle East Pancreatic Cancer Drugs Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 196: Pancreatic Cancer Drugs Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Therapy for the Period 2018-2025
Table 197: Rest of Middle East Pancreatic Cancer Drugs Historic
Market Analysis in US$ Million by Therapy: 2009-2017
Table 198: Rest of Middle East Pancreatic Cancer Drugs Market
Share Breakdown by Therapy: 2009 VS 2019 VS 2025
AFRICA
Table 199: African Pancreatic Cancer Drugs Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 200: Pancreatic Cancer Drugs Market in Africa by Type: A
Historic Review in US$ Million for 2009-2017
Table 201: African Pancreatic Cancer Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 202: African Pancreatic Cancer Drugs Market Estimates and
Projections in US$ Million by Therapy: 2018 to 2025
Table 203: Pancreatic Cancer Drugs Market in Africa by Therapy:
A Historic Review in US$ Million for 2009-2017
Table 204: African Pancreatic Cancer Drugs Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

AMGEN
CELGENE CORPORATION
CLOVIS ONCOLOGY
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE AG
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
PFIZER
PHARMACYTE BIOTECH INC.
TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818014/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.